Zacks: Analysts Expect LifePoint Health Inc (LPNT) Will Announce Quarterly Sales of $1.56 Billion

Wall Street analysts forecast that LifePoint Health Inc (NASDAQ:LPNT) will announce sales of $1.56 billion for the current quarter, according to Zacks. Nine analysts have made estimates for LifePoint Health’s earnings, with the highest sales estimate coming in at $1.59 billion and the lowest estimate coming in at $1.53 billion. LifePoint Health reported sales of $1.58 billion during the same quarter last year, which would suggest a negative year over year growth rate of 1.3%. The company is scheduled to announce its next earnings results on Friday, October 26th.

According to Zacks, analysts expect that LifePoint Health will report full-year sales of $6.29 billion for the current financial year, with estimates ranging from $6.22 billion to $6.33 billion. For the next year, analysts expect that the firm will report sales of $6.43 billion, with estimates ranging from $6.38 billion to $6.53 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research firms that that provide coverage for LifePoint Health.

LifePoint Health (NASDAQ:LPNT) last issued its earnings results on Friday, July 27th. The company reported $1.27 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.19. The business had revenue of $1.57 billion for the quarter, compared to analysts’ expectations of $1.58 billion. LifePoint Health had a return on equity of 7.04% and a net margin of 0.65%. The company’s quarterly revenue was down 1.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.96 EPS.

LPNT has been the topic of a number of recent research reports. Royal Bank of Canada cut LifePoint Health from an “outperform” rating to a “sector perform” rating and set a $65.00 target price on the stock. in a report on Tuesday, July 24th. William Blair restated a “hold” rating on shares of LifePoint Health in a report on Friday, August 17th. BidaskClub cut LifePoint Health from a “hold” rating to a “sell” rating in a report on Wednesday, October 3rd. BMO Capital Markets lifted their target price on LifePoint Health from $62.00 to $65.00 and gave the stock a “market perform” rating in a report on Tuesday, July 24th. Finally, Mizuho set a $65.00 target price on LifePoint Health and gave the stock a “hold” rating in a report on Monday, July 23rd. One research analyst has rated the stock with a sell rating, fifteen have issued a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company’s stock. LifePoint Health currently has an average rating of “Hold” and an average target price of $59.57.

Shares of NASDAQ LPNT traded up $0.04 during mid-day trading on Friday, reaching $64.40. The company had a trading volume of 402,787 shares, compared to its average volume of 626,633. The company has a quick ratio of 1.63, a current ratio of 1.85 and a debt-to-equity ratio of 1.27. The stock has a market capitalization of $2.49 billion, a price-to-earnings ratio of 17.74, a PEG ratio of 1.62 and a beta of 0.64. LifePoint Health has a 1-year low of $41.45 and a 1-year high of $65.35.

Institutional investors have recently modified their holdings of the company. Point72 Asia Hong Kong Ltd boosted its position in shares of LifePoint Health by 1,897.5% in the first quarter. Point72 Asia Hong Kong Ltd now owns 2,417 shares of the company’s stock worth $114,000 after buying an additional 2,296 shares during the period. Cerebellum GP LLC acquired a new stake in shares of LifePoint Health in the third quarter worth $178,000. Bank of Montreal Can acquired a new stake in shares of LifePoint Health in the second quarter worth $169,000. Campbell & CO Investment Adviser LLC acquired a new stake in shares of LifePoint Health in the second quarter worth $211,000. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of LifePoint Health in the second quarter worth $219,000.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.

Featured Article: What is the 52-week high/low?

Get a free copy of the Zacks research report on LifePoint Health (LPNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply